Skip to content

VBI Vaccines Inc/BC

Delisted

CIK 764195fmd_099FNMA7QVF4KTQM6J0ZXY5S7BManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2015 to Mar 31, 2024, 34 periods

Latest annual · FY2023

Millions
Total revenues
9
Gross profit
(8)
Operating income
(80)
Net income
(93)
Free cash flow
(62)

Latest quarter · Q1 FY2024

Millions
Total revenues
1
Operating income
(12)
Net income
(18)
Free cash flow
(12)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
+101.5%
Revenue, 5 yearsFY2018 to FY2023
+20.9%
Net income, 5 yearsFY2018 to FY2023
n/m

VBI Vaccines Inc/BC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$8.7 million$1.1 million+702.4%10-K 2024-04-16 · proof
Operating income-$79.9 million-$81.8 million10-K 2024-04-16 · proof
Net income-$92.8 million-$113.3 million10-K 2024-04-16 · proof
Cash from operating activities-$60.9 million-$73.7 million10-K 2024-04-16 · proof
Free cash flow-$61.8 million-$78 million10-K 2024-04-16 · proof
Total assets$87 million$155.1 million-43.9%10-K 2024-04-16 · proof
Total liabilities$79.4 million$90.9 million-12.6%10-K 2024-04-16 · proof
Cash and cash equivalents$23.7 million$62.6 million-62.2%10-K 2024-04-16 · proof
Total debt$101.5 million10-K 2024-04-16 · proof
What was VBI Vaccines Inc/BC's revenue in fiscal 2023?
VBI Vaccines Inc/BC reported revenue of $8.7 million for fiscal 2023 (the year ended Dec 31, 2023), against $1.1 million the year before (+702.4%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What was VBI Vaccines Inc/BC's operating income in fiscal 2023?
VBI Vaccines Inc/BC reported operating income of -$79.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$81.8 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What was VBI Vaccines Inc/BC's net income in fiscal 2023?
VBI Vaccines Inc/BC reported net income of -$92.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$113.3 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What was VBI Vaccines Inc/BC's cash from operating activities in fiscal 2023?
VBI Vaccines Inc/BC reported cash from operating activities of -$60.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$73.7 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What was VBI Vaccines Inc/BC's free cash flow in fiscal 2023?
VBI Vaccines Inc/BC reported free cash flow of -$61.8 million for fiscal 2023 (the year ended Dec 31, 2023), against -$78 million the year before. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What are VBI Vaccines Inc/BC's total assets?
As of Dec 31, 2023, VBI Vaccines Inc/BC reported total assets of $87 million, against $155.1 million a year earlier (-43.9%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What are VBI Vaccines Inc/BC's total liabilities?
As of Dec 31, 2023, VBI Vaccines Inc/BC reported total liabilities of $79.4 million, against $90.9 million a year earlier (-12.6%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What are VBI Vaccines Inc/BC's cash and cash equivalents?
As of Dec 31, 2023, VBI Vaccines Inc/BC reported cash and cash equivalents of $23.7 million, against $62.6 million a year earlier (-62.2%). Source: the 10-K filed with the SEC on Apr 16, 2024. SEC
What is VBI Vaccines Inc/BC's total debt?
As of Dec 31, 2023, VBI Vaccines Inc/BC reported total debt of $101.5 million. Source: the 10-K filed with the SEC on Apr 16, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:764195&period_type=annual&limit=5"

Information only, not investment advice.